Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Equity Ratio (2019 - 2025)

Historic Equity Ratio for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to 5.57.

  • Volitionrx's Equity Ratio fell 21221.59% to 5.57 in Q3 2025 from the same period last year, while for Sep 2025 it was 5.57, marking a year-over-year decrease of 21221.59%. This contributed to the annual value of 2.78 for FY2024, which is 79109.5% down from last year.
  • As of Q3 2025, Volitionrx's Equity Ratio stood at 5.57, which was down 21221.59% from 3.8 recorded in Q2 2025.
  • In the past 5 years, Volitionrx's Equity Ratio ranged from a high of 0.76 in Q2 2021 and a low of 5.57 during Q3 2025
  • In the last 5 years, Volitionrx's Equity Ratio had a median value of 0.17 in 2022 and averaged 0.99.
  • As far as peak fluctuations go, Volitionrx's Equity Ratio soared by 346.56% in 2021, and later plummeted by 104353.56% in 2024.
  • Quarter analysis of 5 years shows Volitionrx's Equity Ratio stood at 0.64 in 2021, then plummeted by 126.51% to 0.17 in 2022, then crashed by 82.37% to 0.31 in 2023, then tumbled by 791.1% to 2.78 in 2024, then plummeted by 100.7% to 5.57 in 2025.
  • Its Equity Ratio was 5.57 in Q3 2025, compared to 3.8 in Q2 2025 and 3.41 in Q1 2025.